Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025
Rhea-AI Summary
Bioventus (Nasdaq: BVS), a global leader in innovations for active healing, has scheduled its second quarter fiscal year 2025 earnings release and conference call. The company will announce its financial results before market open on Wednesday, August 6, 2025, followed by a management-hosted conference call at 8:30 a.m. Eastern Time.
Investors can participate by dialing 1-800-715-9871 (Conference ID: 1859022) or accessing the webcast through the company's investor relations website. The webcast recording will remain available for replay until August 5, 2026.
[]Positive
- None.
Negative
- None.
DURHAM, N.C., July 29, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the second quarter of fiscal year 2025 before the market opens on Wednesday, August 6, 2025. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.
To participate in the conference call, dial 1-800-715-9871 and refer either to the Bioventus Inc. Conference Call or the conference ID 1859022.
A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until August 5, 2026.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Inquiries:
Dave Crawford
919-474-6787
Dave.Crawford@bioventus.com
FAQ
When will Bioventus (BVS) report Q2 2025 earnings?
How can investors join the Bioventus Q2 2025 earnings call?
What time is the Bioventus (BVS) Q2 2025 earnings conference call?
How long will the Bioventus Q2 2025 earnings webcast be available?
